Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for acute severe colitis - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Crohn's and Colitis Année : 2022

Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for acute severe colitis

, , (1) , (2) , , (3) , (4, 5, 6) , (7, 8) , (9) , , (10)
1
2
3
4
5
6
7
8
9
10
Fichier non déposé

Dates et versions

hal-03665877 , version 1 (12-05-2022)

Identifiants

  • HAL Id : hal-03665877 , version 1

Citer

P. Veyrard, G. Pellet, D. Laharie, M. Nachury, P. Juillerat, et al.. Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for acute severe colitis. Journal of Crohn's and Colitis, 2022, 16 (1), pp.I389-I390. ⟨hal-03665877⟩
6 Consultations
0 Téléchargements

Partager

Gmail Facebook Twitter LinkedIn More